...FDA in 4Q19 for relugolix (TAK-385) to treat uterine fibroids. Zhejiang DTRM Biopharma planning overseas listing Zhejiang DTRM Biopharma Co. Ltd....
...is in Phase Ib testing in China. Brian Moy, Assistant Editor DTRM-12, DTRMWXHS-12 Amicus Therapeutics Inc. Mabpharm Ltd. Myovant Sciences Ltd. Zhejiang DTRM Biopharma Co. Ltd. Zhejiang...

...Cowin Capital Group , Korea Investment Partners , Elite Capital Ph II Cardiovascular 2011 Zhejiang DTRM Biopharma Co. Ltd....

...Zhejiang DTRM Biopharma Co. Ltd. (Zhejiang, China) raised a series A round on Jan. 2 worth more...
...lymphocytic leukemia (CLL), and is being tested as monotherapy and in combinations. Zhejiang DTRM Biopharma Co. Ltd., Zhejiang, China Allison Johnson DTRM-12 Zhejiang DTRM Biopharma Co. Ltd. Bruton's...

...Zhejiang DTRM Biopharma Co. Ltd. (Zhejiang, China) raised a series A round worth more than $60 million...
...lymphoma and chronic lymphocytic leukemia (CLL), and is being tested as monotherapy and in combinations. Allison Johnson DTRM-12 Zhejiang DTRM Biopharma Co. Ltd. Bruton's...

...automated system CD19-positive cancer relapsed after allo-SCT Engraftment and expansion in first 2 patients 1993 Zhejiang DTRM Biopharma Co. Ltd....